Thomas A. Haag, Partner, Seyfarth Shaw LLP, to Speak at TKG's Understanding the BPCIA Litigation Pathway LIVE Webcast
The Knowledge Group, the leading producer of regulatory focused webcasts, has announced today that Thomas A. Haag, Partner, Seyfarth Shaw LLP will speak at The Knowledge Group’s webcast entitled: “Understanding the BPCIA Litigation Pathway Amidst the Increasing Biosimilar Disputes LIVE Webcast”.
- New York, NY (1888PressRelease) October 27, 2017 - This event is scheduled for November 6, 2017 from 12:00 PM - 2:00 PM (ET).
For further details, please visit:
https://www.theknowledgegroup.org/webcasts/legal/intellectual-property-law/understanding-the-bpcia-litigation-pathway
About Thomas A. Haag
Thomas Haag is a partner in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington D.C. office where he cochairs the firm’s chemical & life science patent team. His practice focuses on pharmaceutical and biotechnology patent counseling, due diligence and licensing/transactional matters; as well as Hatch-Waxman litigation and patent opinion work.
He has extensive experience strategically managing large patent portfolios, drafting and negotiating biomedical patent licenses, asset purchase agreements and joint development agreements. Dr. Haag’s technical expertise is in molecular biology related technologies including those in the fields of immuno-oncology, cancer/infectious disease vaccines, nucleic acid-based therapeutics, stem-cell therapeutics, gene editing and therapy, epigenetics, transgenic plants, next generation sequencing (NGS), biologics and biosimilars.
Previously, Dr. Haag was a Founding Partner and Chair of Fanelli Haag PLLC. Fanelli Haag was acquired by Seyfarth Shaw LLP in October 2016. Fanelli Haag was a leading intellectual property boutique law firm focused on issues facing the biotechnology, pharmaceutical, nanotechnology and chemical industries.
About Seyfarth Shaw LLP
Seyfarth Shaw LLP has more than 850 attorneys and provides a broad range of legal services in the areas of intellectual property, labor and employment, employee benefits, litigation, corporate and real estate. With offices in Atlanta, Boston, Chicago, Houston, London, Los Angeles, Melbourne, New York, Sacramento, San Francisco, Shanghai, Sydney and Washington, D.C., Seyfarth’s clients include over 300 of the Fortune 500 companies and reflect virtually every industry and segment of the economy. A recognized leader in delivering value and innovation for legal services, Seyfarth’s acclaimed SeyfarthLean client service model has earned numerous accolades from a variety of highly respected third parties, including industry associations, consulting firms and media. For more information, please visit www.seyfarth.com.
Event Synopsis:
The Biologics Price Competition and Innovation Act (BPCIA) encourages competition and innovation in the biologics market by providing an abridged pathway for the approval of a biosimilar license application along with a twelve-year market exclusivity. The BPCIA also determines patent infringement disputes by setting out a process and addresses potential litigation following a license application. To streamline biosimilar litigation, the BPCIA implements patent statutes that introduce a new artificial patent infringement act, requires information exchange cycles, envisions two waves of litigation, and restricts patent declaratory judgment actions under certain conditions.
Biosimilar litigation is expected to rise as the number of drug manufacturers considering the addition of biosimilars to their drug product portfolios, continues to grow. To dodge costly pitfalls and irreversible mistakes, a complete understanding of the BPCIA litigation pathway should be considered.
The Knowledge Group has assembled a panel of key thought leaders and professionals to help the audience better comprehend the BPCIA Litigation landscape amidst the increasing Biosimilar Disputes. This panel will also present an in-depth analysis and understanding on the current issues surrounding biosimilar litigation and will provide the audience with practical strategies in bringing out the best in these lawsuits in a rapidly evolving legal climate.
Key topics include:
• An Overview of the BPCIA
• The BPCIA Litigation Pathway
• Notable Cases
• Practical Litigation Strategies
• Trends, Developments and Updates
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam